Results 21 to 30 of about 1,397,954 (306)
Near-infrared Autofluorescence Features of Parathyroid Carcinoma
Journal of the Endocrine Society, 2022 Introduction Parathyroid carcinoma is very rare, and intraoperative definitive diagnosis can be elusive with currently available diagnostics. Near-infrared (NIR) autofluorescence is an emerging tool that identifies parathyroid glands in real time.
A. Merrill +6 more
semanticscholar +1 more source
Synchronous parathyroid carcinoma and papillary thyroid carcinoma
Clinical Case Reports, 2022 The simultaneous occurrence of parathyroid carcinoma and nonmedullary thyroid carcinoma is unusual. We report the case of 60‐year‐old woman who was found to have concurrent parathyroid carcinoma with severe clinical manifestations of primary ...
Ibtissem Ben Nacef +8 more
doaj +1 more source
Challenges in the Diagnosis of Parathyroid Cancer: Unraveling the Diagnostic Maze
Reports, 2023 Parathyroid carcinoma (PC) is a rare and aggressive cancer affecting the parathyroid glands, presenting diagnostic and therapeutic challenges due to its rarity and overlapping features with benign parathyroid disease.
Mihaela Stanciu +5 more
doaj +1 more source
Filamin A and Parafibromin Expression in Parathyroid Carcinoma.
European Journal of Endocrinology, 2021 OBJECTIVE Parathyroid carcinoma (PC), atypical parathyroid tumors (APT) and parathyroid adenoma (PA) present with hypercalcemia. Diminished calcium-sensing receptor (CaSR) expression is reported in PC but is rare in benign tumours. Filamin A (FLNA) binds
Sara Storvall +6 more
semanticscholar +1 more source
BMC Endocrine Disorders, 2021 Background Parathyroid carcinoma is a rare endocrine malignancy, rarer when synchronous with a non medullary well differentiated thyroid carcinoma. Parathyroid carcinoma accounts of 0.005% of all malignant tumors and it is responsible for less than 1% of
Nadia De Falco +11 more
doaj +1 more source
Markers for internal neoplasia in the horse
Veterinary Medicine and Science, Volume 9, Issue 1, Page 132-143, January 2023., 2023 The measurement of tumour markers in horses should be performed only in risk groups or in patients with suspicious clinical/laboratory findings (paraneoplastic syndromes). The results should be interpreted with caution as many factors (e.g., young age, pregnancy and inflammation) affect their concentration or activity.
Karolina Drozdzewska, Heidrun Gehlen
wiley +1 more source
Left parathyroid carcinoma with secondary hyperparathyroidism: a case report
BMC Endocrine Disorders, 2023 Background Parathyroid carcinoma is a rare disease with a frequency of 0.005% of all malignancies [1, 2]. Various aspects of its pathogenesis, diagnosis, and treatment remain poorly understood.
Ko Yokoyama +2 more
doaj +1 more source
Cytokeratin 13 (CK13) expression in cancer: a tissue microarray study on 10,439 tumors
APMIS, Volume 131, Issue 2, Page 77-91, February 2023., 2023 Cytokeratin 13 (CK13) is a type I acidic low molecular weight cytokeratin, which is mainly expressed in urothelium and in the squamous epithelium of various sites of origin. Loss of CK13 has been implicated in the development and progression of squamous epithelial neoplasms. To comprehensively determine CK13 expression in normal and neoplastic tissues,
Maximilian Lennartz +25 more
wiley +1 more source
Endocrine Connections, 2023 Nineteen cases of parathyroid carcinoma in patients with multiple endocrine neoplasia type 1 have been reported in the literature, of which 11 carry an inactivating germline mutation in the MEN1 gene.
Sara Lomelino Pinheiro +5 more
doaj +1 more source
Gαq signalling from endosomes: A new conundrum
British Journal of Pharmacology, EarlyView., 2023 Abstract G‐protein‐coupled receptors (GPCRs) constitute the largest family of membrane receptors, and are involved in the transmission of a variety of extracellular stimuli such as hormones, neurotransmitters, light and odorants into intracellular responses.
Carole Daly, Bianca Plouffe
wiley +1 more source